感染疾病診斷市場按技術、疾病類型（腹瀉疾病、呼吸道感染疾病、血液感染疾病）、最終用戶和地區分類

Infectious Disease Diagnostics Market, By Technology, By Disease Indication, Diarrheal Disease,Respiratory Infections,Blood Infections, By End User, By Geography

出版日期: 2025年12月24日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，感染疾病診斷市場在 2025 年的價值為 17.508 億美元，預計到 2032 年將達到 33.708 億美元，從 2025 年到 2032 年的年複合成長率（CAGR）為 9.81%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	17.508億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	9.81%	2032 年的預測值：	33.708億美元

感染疾病是由細菌、病毒、真菌和寄生蟲等微生物引起的，並且可以在不同物種之間傳播。它們透過直接接觸或間接途徑（例如昆蟲叮咬和食物、土壤、水和空氣等污染物）在人與人之間傳播。這些疾病的診斷包括識別病原體及其種類，並確定感染疾病是否正在擴散。診斷是疾病檢測的第一步，而治療則是根除疾病的關鍵。感染疾病是導致感染疾病和死亡率的主要原因之一。診斷在製定臨床治療策略中發揮重要作用。雖然感染疾病診斷對診斷病原體引起的疾病很有用，但像愛滋病、結核病、瘧疾和流感等感染疾病非常普遍，可以使用針對每種疾病的診斷測試進行有效診斷。傳統的感染疾病診斷耗時較長。這促使快速、準確、便攜的就地檢驗產品在感染疾病診斷市場中湧現。就地檢驗在患者附近快速診斷感染疾病，並提供即時結果。目前，多位研究人員正在開發多重照護現場診斷技術。這些診斷測試中使用的技術可分為生化方法、分子技術、免疫診斷、傳統培養方法和染色技術。生化方法包括酵素免疫分析法（ELISA）和凝集反應，而分子技術包括聚合酵素鏈鎖反應（PCR）和次世代定序。這些測試能夠以高通量準確診斷感染疾病。

市場動態

由於人們對早期疾病診斷的意識不斷增強，感染疾病診斷市場日益普及預計將推動預測期內市場成長。例如，根據美國疾病管制與預防中心 (CDC) 1995 年發布的數據，美國醫院每年因院內感染 (HAI) 導致 170 萬例感染和 9.9 萬人死亡。在所有醫療相關感染疾病中，尿道感染佔比高達 32%，其次是手術部位感染（22%）、肺炎（15%）和血流感染疾病（14%）。

本次調查的主要特點

本報告對全球感染疾病診斷市場進行了詳細分析，以 2024 年為基準年，給出了 2025 年至 2032 年的市場規模和複合年成長率 (%)。
它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、區域前景以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數介紹了全球感染疾病診斷市場主要企業的概況：公司概況、財務表現、產品系列、地理擴張、分銷策略、主要發展、策略和未來計劃。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球感染疾病診斷市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過市場分析中使用的各種策略矩陣，相關人員將能夠輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東地區
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratries
BioMerieux
Hologic, Inc.
Danaher Corportion
Thermo Fisher Scientific, Inc.
Roche Diagnostics
DiaSorin SpA
Quidel Corporation
Bio-Rad Laboratories, Inc

第9章各節

調查方法
關於本公司

簡介目錄

Product Code: CMI1971

Infectious Disease Diagnostics Market is estimated to be valued at USD 1,750.8 Mn in 2025 and is expected to reach USD 3,370.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.81% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1,750.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.81%	2032 Value Projection:	USD 3,370.8 Mn

Infectious diseases are caused by organisms such as bacteria, virus, fungi, and parasites and are capable of transmission from one species to another species. Infectious diseases spread from person to person either through direct contact or indirectly through insect bites or other vectors like food, soil, water, and air. Diagnosis of these diseases involves identifying the pathogen and its type and then diagnose infection has spread. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. Infectious diseases are among the leading causes of morbidity and death. Diagnostics plays important part in deciding the course of any clinical treatment. While Infectious diseases diagnostics help in diagnosing disease caused because of pathogenic disease Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Traditional infectious disease diagnosis was time-consuming. Because of this factor, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. Point of care testing helps for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, conventional culturing, and staining techniques. Biochemical techniques include Enzyme-linked Immunosorbent Assay (ELISA), agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Market Dynamics

Increasing prevalence of Infectious Disease Diagnostics Market is expected to drive the market growth over the forecast period, due to growing awareness for the early disease diagnostics. For instance, In 1995, According to the Centers for Disease Control and Prevention {CDCP}, Hospital-acquired infections( HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all, the urinary tract infections occurs up to 32% of all the healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections [14%].

Key features of the study

This report provides in-depth analysis of the global infectious disease diagnostics market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global infectious disease diagnostics market based on the following parameters -company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
Global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

Technology Insights (Revenue, USD Mn & KT, 2025 - 2032)
- ELISA
- Polymerase Chain Reaction
- Immunoassays
- Cell Cultures
- Others
Disease Indication Insights (Revenue, USD Mn & KT, 2025 - 2032)
- Central nervous system (CNS) Infection
- Meningitis
- Brain Abscess
- Diarrheal Disease
- Shigellosis
- Cholera
- Enteric/Typhoid Fever
- Respiratory Infections
- Tuberculosis
- Influenza
- Bronchitis
- Blood Infections
- Malaria
- Dengue
- Infectious Mononucleosis
- Others
- STDs
- Chlamydia
- AIDS
- Syphilis
- Others
End User Insights (Revenue, USD Mn & KT, 2025 - 2032)
- Hospitals
- Diagnostics centers
- Dermatology Clinics
- Others (Research Institutes, Specialty Centres, etc.)
Regional Insights (Revenue, USD Mn & KT, 2025 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players Insights
- Becton Dickinson & Company
- Cepheid, Inc
- Abbott Laboratories
- BioMerieux SA
- Hologic, Inc
- Danaher Corporation
- Thermo Fisher Scientific, Inc
- Roche Diagnostics
- DiaSorin S.p.A
- Quidel Corporation
- Bio-Rad Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Disease Indication
- Market Snapshot, By End Users
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis

4. Global Infectious Disease Diagnostics Market, By Technology, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
- Segment Trends
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Segment Trends
Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Segment Trends
Cell Cultures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Segment Trends

5. Global Infectious Disease Diagnostics Market , By Disease Indication 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Central Nervous System Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Meningitis
Brain Abscess
Diarrheal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Tuberculosis
Influenza
Bronchitis
Blood Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Malaria
Dengue
Infectious Mononucleosis
Others
Sexually transmitted diseases (STDs),
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Chlamydia
AIDS
Syphilis
Others

6. Global Infectious Disease Diagnostics Market , By End Users 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Research Institutes, Specialty Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Infectious Disease Diagnostics Market , By Region, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, Technology , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Becton Dickinson & Company
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Cepheid, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Abbott Laboratries
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
BioMerieux
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Hologic, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Danaher Corportion
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
DiaSorin S.p.A.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Quidel Corporation
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies